Rhizoma Smilacis Glabrae inhibits pathogen-induced upper genital tract inflammation in rats through suppression of NF-κB pathway

Ethnopharmacological relevance: Rhizoma Smilacis Glabrae (RSG) is traditionally used to treat gynecological disease, which is simply recorded in Chinese Pharmacopoeia. However, whether it has effect on upper genital tract inflammation (UGTI) isunclear. Aim of the study: To evaluate the pharmacological effect of RSG on UGTI in rats and analyze its phytochemistry characteristics. Materials and methods: The substances in RSG extract was qualified by LC-Q-TOF-MS method, and 11 substances were further quantified. The RSG extract, at dose of 241, 482 (clinical dose) and 964 mg/kg/day, was orally administered to UGTI rats whose upper genital tracts were multi-infected with pathogens. Infiltrations of neutrophil and lymphocyte and productions of IL-10, IL-6, CXCL-1, MCP-1, RANTES, PGE2, COX-2, NF-kappa B p65 and I kappa B-alpha in upper genital tract were examined to evaluate the effects of RSG and its potential mechanism. Results: A total of 77 substances were detected in RSG extract, with 50 substances putatively identified, most of which were flavonoids, phenolic acids and phenylpropanoids. The quantification analysis showed flavonoid had a relative high amount. In pharmacological study, RSG extract suppressed infiltrations of inflammatory cells, reduced over-productions of factors involved in inflammation and pelvic pain. A potential mechanism of these effects was blocking NF-kappa B signal pathway. Conclusions: The RSG extract exhibited anti-inflammatory effect on UGTI, with a potential mechanism of blocking the activation of NF-kappa B signal pathway. The effect may be involved in the presence of substances, such as flavonoids and phenolic acids.